OBJECTIVES: To assess polysomnogram (PSG) results and global and disease-specific quality of life (QOL) in children with obstructive sleep apnea (OSA), before and after adenotonsillectomy, and to assess the association between PSG findings and QOL. DESIGN: Prospective observational study. We performed overnight PSG using standardized techniques and assessed disease-specific and global QOL using validated instruments. Follow-up was assessed at 1 year. We compared QOL outcomes between children who underwent adenotonsillectomy and children who did not. SETTING: A large tertiary care children's hospital. PATIENTS: Children with sleep-disordered breathing who were suspected of having OSA. INTERVENTION: Adenotonsillectomy. MAIN OUTCOME MEASURES: We evaluated PSG parameters, disease-specific QOL, and global QOL. RESULTS: We enrolled 47 children, 31 of whom met PSG criteria for OSA. Disease-specific and global QOL were not significantly different between children with OSA and children without. Global QOL was significantly worse for children with OSA than healthy children on several subscales: general health perception, behavior, and parental impact-emotional. Children who underwent adenotonsillectomy had significant improvements in QOL scores and PSG parameters (apnea-hypopnea index, P = .004; minimum saturation, P = .004). We found significantly larger QOL changes in children who underwent surgery compared with children without surgery (subscales: infections, P = .01; airway, P = .002; swallowing, P = .02; and behavior, P = .03). No strong association was identified between QOL scores and PSG parameters. CONCLUSIONS: Children with OSA and sleep-disordered breathing have significantly worse QOL than healthy children. However, the association between PSG findings and QOL was only moderate. Children with OSA treated with adenotonsillectomy demonstrated large improvements in disease-specific and global QOL as well as PSG parameters.
OBJECTIVES: To assess polysomnogram (PSG) results and global and disease-specific quality of life (QOL) in children with obstructive sleep apnea (OSA), before and after adenotonsillectomy, and to assess the association between PSG findings and QOL. DESIGN: Prospective observational study. We performed overnight PSG using standardized techniques and assessed disease-specific and global QOL using validated instruments. Follow-up was assessed at 1 year. We compared QOL outcomes between children who underwent adenotonsillectomy and children who did not. SETTING: A large tertiary care children's hospital. PATIENTS: Children with sleep-disordered breathing who were suspected of having OSA. INTERVENTION: Adenotonsillectomy. MAIN OUTCOME MEASURES: We evaluated PSG parameters, disease-specific QOL, and global QOL. RESULTS: We enrolled 47 children, 31 of whom met PSG criteria for OSA. Disease-specific and global QOL were not significantly different between children with OSA and children without. Global QOL was significantly worse for children with OSA than healthy children on several subscales: general health perception, behavior, and parental impact-emotional. Children who underwent adenotonsillectomy had significant improvements in QOL scores and PSG parameters (apnea-hypopnea index, P = .004; minimum saturation, P = .004). We found significantly larger QOL changes in children who underwent surgery compared with children without surgery (subscales: infections, P = .01; airway, P = .002; swallowing, P = .02; and behavior, P = .03). No strong association was identified between QOL scores and PSG parameters. CONCLUSIONS:Children with OSA and sleep-disordered breathing have significantly worse QOL than healthy children. However, the association between PSG findings and QOL was only moderate. Children with OSA treated with adenotonsillectomy demonstrated large improvements in disease-specific and global QOL as well as PSG parameters.
Authors: Angela R Jackman; Sarah N Biggs; Lisa M Walter; Upeka S Embuldeniya; Margot J Davey; Gillian M Nixon; Vicki Anderson; John Trinder; Rosemary S C Horne Journal: Sleep Date: 2013-11-01 Impact factor: 5.849
Authors: R Bovo; P Trevisi; E Zanoletti; D Cazzador; T Volo; E Emanuelli; A Martini Journal: Acta Otorhinolaryngol Ital Date: 2017-10 Impact factor: 2.124
Authors: Merrill S Wise; Cynthia D Nichols; Madeleine M Grigg-Damberger; Carole L Marcus; Manisha B Witmans; Valerie G Kirk; Lynn A D'Andrea; Timothy F Hoban Journal: Sleep Date: 2011-03-01 Impact factor: 5.849
Authors: Susan L Garetz; Ron B Mitchell; Portia D Parker; Reneé H Moore; Carol L Rosen; Bruno Giordani; Hiren Muzumdar; Shalini Paruthi; Lisa Elden; Paul Willging; Dean W Beebe; Carole L Marcus; Ronald D Chervin; Susan Redline Journal: Pediatrics Date: 2015-01-19 Impact factor: 7.124
Authors: Seockhoon Chung; Elise K Hodges; Deborah L Ruzicka; Timothy F Hoban; Susan L Garetz; Kenneth E Guire; Barbara T Felt; James E Dillon; Ronald D Chervin; Bruno Giordani Journal: Int J Pediatr Otorhinolaryngol Date: 2015-11-10 Impact factor: 1.675
Authors: James E Dillon; Sarah Blunden; Deborah L Ruzicka; Kenneth E Guire; Donna Champine; Robert A Weatherly; Elise K Hodges; Bruno J Giordani; Ronald D Chervin Journal: J Am Acad Child Adolesc Psychiatry Date: 2007-11 Impact factor: 8.829
Authors: Maria Pia Villa; Rosa Castaldo; Silvia Miano; Maria Chiara Paolino; Ottavio Vitelli; Alessandra Tabarrini; Anna Rita Mazzotta; Manuela Cecili; Mario Barreto Journal: Sleep Breath Date: 2013-11-26 Impact factor: 2.816